Book Signing Elsevier Authors Eric J. Topol, MD and Paul S. Teirstein, MD at TCT 2011
Philadelphia, PA, November 8, 2011 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that Eric J. Topol, MD and Paul S. Teirstein, MD, authors of the newly published sixth edition of “Textbook of Interventional Cardiology,” will participate in a book signing and live recording of the Click & Rub Podcast. The event will take place at the Transcatheter Cardiovascular Therapeutics (TCT) 2011 annual meeting at 9:00am on Wednesday, November 9th at the Scripps Health Booth, #2535. Attendees are encouraged to stop by and meet the authors in person and get their book signed. Copies of the new edition will be available for sale at the nearby Elsevier Booth, #2435.
Drs. Topol and Teirstein, thought leaders from Scripps Translational Research Institute, regularly broadcastClick & Rub via theheart.org and offer a freewheeling and unconventional exchange on the latest cardiology news and events. In the new edition of Textbook of Interventional Cardiology, they provide comprehensive coverage of the ever-evolving practice and emerging procedures like transcatheter aortic valve implantation (TAVI), transradial intervention, and optical coherence tomography (OCT), as well as new interventional approaches for left main stem disease and thrombus-containing lesions.
The Elsevier exhibition booth (#2535) will be open at the Transcatheter Cardiovascular Therapeutics 2011 annual meeting at the Moscone Center, San Francisco, CA from Tuesday, November 8th through Thursday, November 10th, displaying the new edition of Topol & Teirstein’s Textbook of Interventional Cardiology and other top cardiology books, journals, and electronic reference tools.About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
+1 215 239 3509